Narcolepsy Therapy Expanding Worldwide
Global narcolepsy therapeutics market is expected to reach over USD 1,996.06 million by 2020, according to a new study by Grand View Research Inc. Growing prevalence of the target disease is anticipated to be the key driver for narcolepsy therapeutics industry growth. According to the estimates by the Narcolepsy Network, approximately 1 in 2,000 people in the U.S. suffer from the target disease. Steep increase in the incidence rates of the disease was observed in several countries of Europe after H1N1 vaccination program in 2009, which led to rise in awareness about this rare disorder.
-Grand View Research
Latest posts by Physician Reviewed M.D. (see all)
- Ask The Sleep Doctor: Sleep and Appearance, Sleep and Alzheimer’s and Sleep and Hyperactivity - March 24, 2019
- Ask The Sleep Doctor:Depression and Sleep, Sleep Apps and Sleep Apnea and Car Accidents - February 12, 2019
- Ask The Sleep Doctor:Sleep Apnea in Child, Palpitations, Coffee and Sleep and more - January 18, 2019